ProQR Therapeutics N.V. buy Cantor Fitzgerald
Start price
27.06.25
/
50%
€1.84
Target price
27.06.26
€6.84
Performance (%)
-21.91%
Price
16.01.26
€1.42
Summary
This prediction is currently active. The prediction for ProQR Therapeutics N.V. disappoints with a performance of -21.91%. This prediction currently runs until 27.06.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | -5.396% | -5.396% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by Cantor_Fitzgerald for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics N.V. (NASDAQ: PRQR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $8.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.38
29.04.25
29.04.25
€7.02
29.04.26
29.04.26
4.21%
16.01.26
16.01.26
